 Bruce Lanser
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 11 | 2023 | 254 | 3.530 |
Why?
| | Allergens | 14 | 2023 | 417 | 2.340 |
Why?
| | Desensitization, Immunologic | 11 | 2022 | 117 | 1.990 |
Why?
| | Peanut Hypersensitivity | 7 | 2021 | 199 | 1.220 |
Why?
| | Anaphylaxis | 5 | 2022 | 148 | 1.050 |
Why?
| | Immunotherapy | 2 | 2020 | 474 | 0.930 |
Why?
| | Sesamum | 1 | 2023 | 6 | 0.860 |
Why?
| | Epinephrine | 3 | 2022 | 167 | 0.840 |
Why?
| | Hypersensitivity | 2 | 2023 | 256 | 0.810 |
Why?
| | Arachis | 5 | 2021 | 147 | 0.810 |
Why?
| | Dermatitis, Atopic | 2 | 2021 | 310 | 0.620 |
Why?
| | Pyroglyphidae | 1 | 2018 | 17 | 0.610 |
Why?
| | Milk | 2 | 2023 | 124 | 0.610 |
Why?
| | Humidity | 1 | 2018 | 37 | 0.610 |
Why?
| | Ovum | 1 | 2017 | 28 | 0.600 |
Why?
| | Rhinitis, Allergic | 1 | 2018 | 35 | 0.590 |
Why?
| | Shock | 1 | 2018 | 76 | 0.560 |
Why?
| | Fungi | 1 | 2018 | 124 | 0.560 |
Why?
| | Child Care | 1 | 2016 | 23 | 0.530 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 340 | 0.520 |
Why?
| | Eosinophils | 1 | 2017 | 281 | 0.510 |
Why?
| | Omalizumab | 3 | 2022 | 46 | 0.510 |
Why?
| | Food | 3 | 2023 | 160 | 0.470 |
Why?
| | Skin | 1 | 2018 | 659 | 0.460 |
Why?
| | Teaching | 1 | 2016 | 223 | 0.450 |
Why?
| | Eosinophilic Esophagitis | 1 | 2017 | 295 | 0.440 |
Why?
| | Child | 15 | 2023 | 18468 | 0.370 |
Why?
| | Diet | 2 | 2023 | 1075 | 0.340 |
Why?
| | Caregivers | 1 | 2016 | 716 | 0.330 |
Why?
| | Child, Preschool | 8 | 2020 | 9124 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1190 | 0.300 |
Why?
| | Biological Products | 2 | 2020 | 171 | 0.280 |
Why?
| | Asthma | 1 | 2018 | 2051 | 0.250 |
Why?
| | Humans | 22 | 2023 | 115222 | 0.220 |
Why?
| | Milk Hypersensitivity | 1 | 2023 | 22 | 0.210 |
Why?
| | Egg Hypersensitivity | 1 | 2023 | 45 | 0.210 |
Why?
| | Food Assistance | 1 | 2021 | 25 | 0.190 |
Why?
| | Skin Tests | 2 | 2020 | 123 | 0.190 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2020 | 14 | 0.180 |
Why?
| | Interleukin-13 | 1 | 2020 | 123 | 0.170 |
Why?
| | Enterocolitis | 1 | 2020 | 33 | 0.170 |
Why?
| | Curriculum | 2 | 2016 | 848 | 0.170 |
Why?
| | Th2 Cells | 1 | 2020 | 155 | 0.160 |
Why?
| | Transdermal Patch | 1 | 2019 | 15 | 0.160 |
Why?
| | Humidifiers | 1 | 2018 | 1 | 0.150 |
Why?
| | Plant Proteins | 1 | 2018 | 81 | 0.150 |
Why?
| | Administration, Oral | 4 | 2021 | 731 | 0.150 |
Why?
| | Allergists | 1 | 2018 | 19 | 0.150 |
Why?
| | Adolescent | 6 | 2020 | 17889 | 0.140 |
Why?
| | Schools | 1 | 2020 | 400 | 0.140 |
Why?
| | Immune Tolerance | 1 | 2018 | 329 | 0.140 |
Why?
| | Hot Temperature | 1 | 2017 | 304 | 0.130 |
Why?
| | Animals | 5 | 2023 | 31884 | 0.130 |
Why?
| | Anti-Allergic Agents | 1 | 2015 | 41 | 0.120 |
Why?
| | Probiotics | 1 | 2015 | 46 | 0.120 |
Why?
| | Immunoglobulin E | 3 | 2020 | 323 | 0.120 |
Why?
| | Needs Assessment | 1 | 2016 | 317 | 0.120 |
Why?
| | Leadership | 1 | 2015 | 296 | 0.100 |
Why?
| | Double-Blind Method | 3 | 2020 | 1665 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2015 | 683 | 0.090 |
Why?
| | Infant | 3 | 2021 | 7966 | 0.090 |
Why?
| | Administration, Cutaneous | 2 | 2020 | 117 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2018 | 3547 | 0.080 |
Why?
| | Colorado | 1 | 2018 | 4099 | 0.080 |
Why?
| | Internship and Residency | 1 | 2015 | 951 | 0.060 |
Why?
| | Cooking | 1 | 2023 | 48 | 0.050 |
Why?
| | Nuts | 1 | 2022 | 12 | 0.050 |
Why?
| | Mice | 1 | 2018 | 14934 | 0.050 |
Why?
| | Male | 5 | 2020 | 55814 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2020 | 9151 | 0.050 |
Why?
| | Female | 5 | 2020 | 59720 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2018 | 12597 | 0.050 |
Why?
| | Food Supply | 1 | 2021 | 62 | 0.050 |
Why?
| | Mucous Membrane | 1 | 2021 | 108 | 0.050 |
Why?
| | Global Burden of Disease | 1 | 2020 | 15 | 0.050 |
Why?
| | Aminoglutethimide | 1 | 2020 | 6 | 0.050 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 99 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2021 | 221 | 0.040 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2018 | 76 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 791 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2019 | 307 | 0.040 |
Why?
| | Transfection | 1 | 2020 | 872 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1130 | 0.040 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 182 | 0.030 |
Why?
| | Eating | 1 | 2019 | 347 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2020 | 1042 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 937 | 0.030 |
Why?
| | Adult | 3 | 2022 | 30711 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2645 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 10520 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1323 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2563 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2020 | 4430 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2900 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3422 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 4527 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 8658 | 0.020 |
Why?
| | United States | 1 | 2021 | 12256 | 0.020 |
Why?
| | Middle Aged | 1 | 2018 | 26873 | 0.010 |
Why?
|
|
Lanser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|